Additionally, another exception occurred while executing the custom error page for the first exception. Let’s see if we can help you out with the following options: You can perform a search at the top of this page or report a broken link to prevent others from ending up with this error. Plaquenil to treat mouth disease Plaquenil and drinking alcohol Plaquenil stopping A baseline ocular examination is recommended within the first year of starting Plaquenil. The baseline exam should include best corrected distance visual acuity BCVA, an automated threshold visual field VF of the central 10 degrees with retesting if an abnormality is noted, and spectral domain ocular coherence tomography SD-OCT. Upon the detection of the visual field defects, the hydroxychloroquine was stopped. She was taking hydroxychloroquine 5.0 mg/kg/day with a duration of 10 years with a cumulative dose of 1460g putting her at increased risk for hydroxychloroquine retinal toxicity. Abstract. Background The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools. This article focuses upon hydroxychloroquine retinopathy. Chloroquine was originally used as an anti-malarial therapeutic. Alternatively, we suggest using this opportunity to take a little break from work and read some of the interesting articles below. Plaquenil retinopathy visual field Hydroxychloroquine Retinopathy Still Alive and Well - The Rheumatologist, Hydroxychloroquine Plaquenil Toxicity and Recommendations. Hydroxychloroquine with skin cancerAralen reviewsPlaquenil interactions with vitaminsWhat does plaquenil do for autoimmune diseases To analyze Humphrey visual field HVF findings in hydroxychloroquine HCQ retinal tests were interpreted retrospectively in this observational case series of 15 patients with HCQ toxicity. Patients seen at Lahey Clinic were identified by. Humphrey visual field findings in hydroxychloroquine toxicity. Recommendations on Screening for Chloroquine and.. Protecting your eyesight when taking Plaquenil Lupus.. A 45-year-old black female presented with no ocular or visual complaints. Her ocular history was unremarkable. However, her medical history was significant for a recent diagnosis of lupus. Her rheumatologist instructed her to undergo a baseline ocular examination prior to initiating Plaquenil hydroxychloroquine, Sanofi-Aventis therapy. Plaquenil Retinopathy Screening Requirements Are You Up to Date on the New Standards. Visual Field 10-2 with Plaquenil induced Bulls Eye Maculopathy c/o Dr. Hydroxychloroquine Maculopathy An Update on Screening and Diagnosis A brief guide for imaging SHIRI SHULMAN, MD. H ydroxychloroquine HCQ; Plaquenil, Sanofi, Bridgewater, NJ is an antimalarial agent that is also commonly used as a treatment for a variety of rheumatologic and dermatologic conditions, such as rheumatoid arthritis and systemic lupus erythematosus.